Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Welch

Showing results (361-370 of 422) with videos related to

Pageof 43
Sort By:
Leukemia|December 7, 2021
Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cellsElisabeth R Wilson, Nichole M Helton, Sharon E Heath, et al.
The New England Journal of Medicine|July 23, 2015
AVI-7288 for Marburg Virus in Nonhuman Primates and HumansAlison E Heald, Jay S Charleston, Patrick L Iversen, et al.
Gynecologic Oncology|January 8, 2017
Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)A Spreafico, A M Oza, B A Clarke, et al.
Haematologica|April 15, 2024
Molecular responses in decitabine- and decitabine/ venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromesAgata Gruszczynska, Abhishek Maiti, Christopher A Miller, et al.
Current Oncology (Toronto, Ont.)|April 25, 2015
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxisJ C Easaw, M A Shea-Budgell, C M J Wu, et al.
American Journal of Hematology|October 7, 2009
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSFMike G Martin, Kristan M Augustin, Geoffrey L Uy, et al.
British Journal of Haematology|November 24, 2018
Exome analysis of treatment-related AML after APL suggests secondary evolutionTianjiao Wang, Meagan A Jacoby, Eric J Duncavage, et al.
Current Oncology (Toronto, Ont.)|April 25, 2015
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatmentJ C Easaw, M A Shea-Budgell, C M J Wu, et al.
Chemical Reviews|May 5, 2022
Beyond the Average: Spatial and Temporal Fluctuations in Oxide Glass-Forming SystemsKatelyn A Kirchner, Daniel R Cassar, Edgar D Zanotto, et al.
Heart, Lung & Circulation|July 15, 2018
Increased Pulmonary-Systemic Pulse Pressure Ratio Is Associated With Increased Mortality in Group 1 Pulmonary HypertensionBenjamin K Ruth, Kenneth C Bilchick, Manu M Mysore, et al.
Pageof 43

Showing results (361-370 of 422) with videos related to

Sort By:
Pageof 43
Leukemia|December 7, 2021
Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cellsElisabeth R Wilson, Nichole M Helton, Sharon E Heath, et al.
The New England Journal of Medicine|July 23, 2015
AVI-7288 for Marburg Virus in Nonhuman Primates and HumansAlison E Heald, Jay S Charleston, Patrick L Iversen, et al.
Gynecologic Oncology|January 8, 2017
Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)A Spreafico, A M Oza, B A Clarke, et al.
Haematologica|April 15, 2024
Molecular responses in decitabine- and decitabine/ venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromesAgata Gruszczynska, Abhishek Maiti, Christopher A Miller, et al.
Current Oncology (Toronto, Ont.)|April 25, 2015
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxisJ C Easaw, M A Shea-Budgell, C M J Wu, et al.
American Journal of Hematology|October 7, 2009
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSFMike G Martin, Kristan M Augustin, Geoffrey L Uy, et al.
British Journal of Haematology|November 24, 2018
Exome analysis of treatment-related AML after APL suggests secondary evolutionTianjiao Wang, Meagan A Jacoby, Eric J Duncavage, et al.
Current Oncology (Toronto, Ont.)|April 25, 2015
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatmentJ C Easaw, M A Shea-Budgell, C M J Wu, et al.
Chemical Reviews|May 5, 2022
Beyond the Average: Spatial and Temporal Fluctuations in Oxide Glass-Forming SystemsKatelyn A Kirchner, Daniel R Cassar, Edgar D Zanotto, et al.
Heart, Lung & Circulation|July 15, 2018
Increased Pulmonary-Systemic Pulse Pressure Ratio Is Associated With Increased Mortality in Group 1 Pulmonary HypertensionBenjamin K Ruth, Kenneth C Bilchick, Manu M Mysore, et al.
Pageof 43